Literature DB >> 712077

Studies on immunosuppression by cobra venom factor. II. On responses to DNP-Ficoll and DNP-Polyacrylamide.

T Matsuda, G P Martinelli, A G Osler.   

Abstract

We have reassessed the effects of CVF administration on the humoral responses to two T-independent immunogens: DNP-Ficoll and DNP-Polyacrylamide. With high immunogen doses, little or no evidence of suppression was found. However, when the immunizing dose was reduced, suppression of both IgG and IgM responses became apparent. As indicated in a previous report, the immunosuppressive effect of CVF on T-dependent responses may result not only from C depletion but also from the generation of C cleavage products that may impair the auxiliary contribution of macrophages to the generation of these humoral responses. A similar mechanism may be applicable to the suppression of antibody production to DNP-Ficoll and DNP-PAA in view of recent reports showing a macrophage requirement for the response to these immunogens.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 712077

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Effects of cobra venom factor treatment on latent feline leukemia virus infection.

Authors:  E H Kraut; J L Rojko; R G Olsen; D L Tuomari
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

2.  T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice.

Authors:  Eva Szomolanyi-Tsuda; Mina O Seedhom; Michael C Carroll; Robert L Garcea
Journal:  Virology       Date:  2006-06-02       Impact factor: 3.616

Review 3.  The role of complement in the induction and regulation of immune responses.

Authors:  T G Egwang; A D Befus
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

Review 4.  Regulation of immune response by components of the complement cascade and their activated fragments.

Authors:  W O Weigle; M G Goodman; E L Morgan; T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1983

5.  An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies.

Authors:  M A Hazlewood; D S Kumararatne; A D Webster; M Goodall; P Bird; M Daha
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.

Authors:  Karen M Haas; Jonathan C Poe; Thomas F Tedder
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

7.  The role of complement in the induction of antibody responses.

Authors:  H D Ochs; R J Wedgwood; M M Frank; S R Heller; S W Hosea
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

8.  Suppression of in vitro antibody response of human peripheral blood lymphocytes by a heat-labile factor in normal human serum.

Authors:  M A Aldo-Benson; B H Petersen; M D Benson
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

9.  Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.

Authors:  A K Matsumoto; J Kopicky-Burd; R H Carter; D A Tuveson; T F Tedder; D T Fearon
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

10.  The structure of an alternate form of complement C3 that displays costimulatory growth factor activity for B lymphocytes.

Authors:  Y Cahen-Kramer; I L Mårtensson; F Melchers
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.